An All-Atom Model of the Structure of Human Copper Transporter 1

Cell Biochemistry and Biophysics

Volumn 63, Issue 3, 2012, Pages 223-234

  Tsigelny, Igor F ^a,b   Sharikov, Yuriy ^a   Greenberg, Jerry P ^b   Miller, Mark A ^b   Kouznetsova, Valentina L ^b,c   Larson, Christopher A ^c   Howell, Stephen B ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cisplatin; Copper; CTR1; Molecular model; Transporter

Indexed keywords

CATION TRANSPORT PROTEIN; CISPLATIN; COPPER; COPPER TRANSPORTER 1;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BINDING SITES; CATION TRANSPORT PROTEINS; CISPLATIN; COPPER; CRYSTALLOGRAPHY, X-RAY; HUMANS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

MAMMALIA;

EID: 84862247776     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9358-x     Document Type: Article

References (47)

1. Puig, S., & Thiele, D. J. (2002). Molecular mechanisms of copper uptake and distribution. Current Opinion in Chemical Biology, 6, 171-180.
2. Linder, M. C., & Hazegh-Azam, M. (1996). Copper biochemistry and molecular biology. American Journal of Clinical Nutrition, 63, 797S-811S.
3. Howell, S. B., Safaei, R., Larson, C. A., & Sailor, M. J. (2010). Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Molecular Pharmacology, 77, 887-894.
4. Crider, S. E., Holbrook, R. J., & Franz, K. J. (2010). Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1. Metallomics, 2, 74-83.
5. Wang, X., Du, X., Li, H., Chan, D. S., & Sun, H. (2011). The effect of the extracellular domain of human copper transporter (hCTR1) on cisplatin activation. Angewandte Chemie (International ed. in English), 50, 2706-2711.
6. Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002). The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Molecular Pharmacology, 62, 1154-1159.
7. Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002). Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proceedings of the National Academy of Sciences of the United States of America, 99, 14298-14302.
8. Larson, C. A., Blair, B. G., Safaei, R., & Howell, S. B. (2009). The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs. Molecular Pharmacology, 75, 324-330.
9. Lee, J., Pena, M. M., Nose, Y., & Thiele, D. J. (2002). Biochemical characterization of the human copper transporter Ctr1. The Journal of Biological Chemistry, 277, 4380-4387.
10. Lee, J., Petris, M. J., & Thiele, D. J. (2002). Characterization of mouse embryonic cells deficient in the Ctr1 high affinity copper transporter. The Journal of Biological Chemistry, 277, 40253-40259.
11. Jiang, J., Nadas, I. A., Alison Kim, M., Franz, K. J. (2005). A mets motif peptide found in copper transport proteins selectively binds Cu(I) with methionine-only coordination. Inorganic Chemistry, 44, 9787-9794.
12. Wu, X., Sinani, D., Kim, H., & Lee, J. (2009). Copper transport activity of yeast Ctr1 is down regulated via its C-terminus in response to excess copper. The Journal of Biological Chemistry, 284, 4112-4122.
13. Petris, M. J., Smith, K., Lee, J., & Thiele, D. J. (2003). Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. The Journal of Biological Chemistry, 278, 9639-9646.
14. Holzer, A. K., & Howell, S. B. (2006). The internalization and degradation of human copper transporter 1 following cisplatin exposure. Cancer Research, 66, 10944-10952.
15. Jandial, D. D., et al. (2009). Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1. Clinical Cancer Research, 15, 553-560.
16. Liang, Z. D., Stockton, D., Savaraj, N., & Kuo, M. T. (2009). Mechanistic comparison of human copper transporter hCtr1-mediated transports between copper ion and cisplatin. Molecular Pharmacology, 76, 843-853.
17. Molloy, S. A., & Kaplan, J. H. (2009). Copper-dependent recycling of hCTR1, the human high affinity copper transporter. The Journal of Biological Chemistry, 284, 29704-29713.
18. Holzer, A. K., Katano, K., Klomp, L. W., & Howell, S. B. (2004). Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clinical Cancer Research, 10, 6744-6749.
19. Guo, Y., Smith, K., Lee, J., Thiele, D. J., & Petris, M. J. (2004). Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. The Journal of Biological Chemistry, 279, 17428-17433.
20. Liu, J., Sitaram, A., & Burd, C. G. (2007). Regulation of copper-dependent endocytosis and vacuolar degradation of the yeast copper transporter, ctr1p, by the rsp5 ubiquitin ligase. Traffic, 8, 1375-1384.
21. Safaei, R., Maktabi, M. H., Blair, B. G., Larson, C. A., & Howell, S. B. (2009). Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. Journal of Inorganic Biochemistry, 103, 333-341.
22. Aller, S. G., & Unger, V. M. (2006). Projection structure of the human copper transporter CTR1 at 6-A resolution reveals a compact trimer with a novel channel-like architecture. Proceedings of the National Academy of Sciences of the United States of America, 103, 3627-3632.
23. De Feo, C. J., Aller, S. G., & Unger, V. M. (2007). A structural perspective on copper uptake in eukaryotes. BioMetals, 20, 705-716.
24. De Feo, C. J., Aller, S. G., Siluvai, G. S., Blackburn, N. J., & Unger, V. M. (2009). Three-dimensional structure of the human copper transporter hCTR1. Proceedings of the National Academy of Sciences of the United States of America, 106, 4237-4242.
25. Jia, Y., Dewey, T. G., Shindyalov, I. N., & Bourne, P. E. (2004). A new scoring function and associated statistical significance for structure alignment by CE. Journal of Computational Biology, 11(5), 787-799.
26. Chivian, D., & Baker, D. (2006). Homology modeling using parametric alignment ensemble generation with consensus and energy-based model selection. Nucleic Acids Research, 34, e112.
27. Raman, S., et al. (2009). Structure prediction for CASP8 with all-atom refinement using Rosetta. Proteins, 77(Suppl 9), 89-99.
28. Sharikov, Y., Walker, R. C., Greenberg, J., Kouznetsova, V., Nigam, S. K., Miller, M. A., Masliah, E., & Tsigelny, I. F. (2008). MAPAS: A tool for predicting membrane-contacting protein surfaces. Nature Methods, 5, 119.
29. Roy, A., Kucukural, A., & Zhang, Y. (2010). I-TASSER: A unified platform for automated protein structure and function prediction. Nature Protocols, 5, 725-738.
30. Roy, A., Xu, D., Poisson, J., & Zhang, Y. (2011). A protocol for computer-based protein structure and function prediction (p. e3259). Journal of visualized experiments: JoVE.
31. Kale, L., et al. (1999). NAMD2: Greater scalability for parallel molecular dynamics. Journal of Computational Physics, 151, 282-312.
32. Feller, S. E., & MacKerell, A. D. (2000). An improved empirical potential energy function for molecular simulations of phospholipids. The Journal of Physical Chemistry B, 104, 7510-7515.
33. Tu, K., Tobias, D. J., & Klein, M. L. (1995). Constant pressure and temperature molecular dynamics simulation of a fully hydrated liquid crystal phase dipalmitoylphosphatidylcholine bilayer. Biophysical Journal, 69, 2558-2562.
34. Feller, S., Zhang, Y., Pastor, R. W., & Brooks, B. R. (1995). Constant pressure molecular dynamics simulation: the Langevin piston method. Journal of Chemical Physics, 103, 4613-4621.
35. Schushan, M., Barkan, Y., Haliloglu, T., & Ben-Tal, N. (2010). C(alpha)-trace model of the transmembrane domain of human copper transporter 1, motion and functional implications. Proceedings of the National Academy of Sciences of the United States of America, 107, 10908-10913.
36. Haas, K. L., Putterman, A. B., White, D. R., Thiele, D. J., & Franz, K. J. (2011). Model peptides provide new insights into the role of histidine residues as potential ligands in human cellular copper acquisition via ctr1. Journal of the American Chemical Society, 133, 4427-4437.
37. Himes, R. A., Park, G. Y., Barry, A. N., Blackburn, N. J., & Karlin, K. D. (2007). Synthesis and X-ray absorption spectroscopy structural studies of Cu(I) complexes of histidylhistidine peptides: The predominance of linear 2-coordinate geometry. Journal of the American Chemical Society, 129, 5352-5353.
38. Rubino, J. T., Chenkin, M. P., Keller, M., Riggs-Gelascob, P., & Franz, K. J. (2011). A comparison of methionine, histidine and cysteine in copper(I)-binding peptides reveals differences relevant to copper uptake by organisms in diverse environments. Metallomics, 3, 61-73.
39. Kim, B. E., Nevitt, T., & Thiele, D. J. (2008). Mechanisms for copper acquisition, distribution and regulation. Nature Chemical Biology, 4, 176-185.
40. Rodriguez-Granillo, A., Crespo, A., Estrin, D. A., & Wittung-Stafshede, P. (2010). Copper-transfer mechanism from the human chaperone Atox1 to a metal-binding domain of Wilson disease protein. The Journal of Physical Chemistry, 114, 3698-3706.
41. Eisses, J. F., & Kaplan, J. H. (2005). The mechanism of copper uptake mediated by human CTR1: A mutational analysis. Journal of Biological Chemistry, 280, 37159-37168.
42. Puig, S., Lee, J., Lau, M., & Thiele, D. J. (2002). Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake. Journal of Biological Chemistry, 277, 26021-26030.
43. Eisses, J. F., & Kaplan, J. H. (2002). Molecular characterization of hCTR1, the human copper uptake protein. Journal of Biological Chemistry, 277, 29162-29171.
44. Xiao, Z., & Wedd, A. G. (2002). A C-terminal domain of the membrane copper pump Ctr1 exchanges copper(I) with the copper chaperone Atx1. Chemical Communications (Cambridge, England), 2, 588-589.
45. Esposito, D. L., Li, Y., Cama, A., & Quon, M. J. (2001). Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology, 142, 2833-2840.
46. Wu, H., Windmiller, D. A., Wang, L., & Backer, J. M. (2003). YXXM motifs in the PDGF-beta receptor serve dual roles as phosphoinositide 3-kinase binding motifs and tyrosine-based endocytic sorting signals. Journal of Biological Chemistry, 278, 40425-40428.
47. Haas K. (2010). Copper at the interface of chemistry and biology: New insights into hCtr1 function and the role of histidine in human cellular copper acquisition. PhD dissertation, Duke University, Durham, NC.